Objectives Tofacitinib is an oral Janus kinase inhibitor for treatment of psoriatic arthritis
(PsA). We evaluated patient-reported outcomes (PROs) in patients with PsA refractory to≥ 1 …

Objectives Tofacitinib is an oral Janus kinase inhibitor for treatment of psoriatic arthritis
(PsA). Patient-reported outcomes (PROs) were evaluated in patients with PsA with …

Abstract Background Cognitive Stimulation Therapy (CST) is considered a gold-standard,
evidence-based and cost-effective approach to improve cognitive function and quality of life …

Introduction Many smokers do not achieve abstinence using current smoking cessation
options. This randomized controlled trial (RCT) investigated a novel nutritional supplement …

The paper reviews of the data available in the literature on the clinical efficacy and safety of
tofacitinib (TOFA) in the treatment of psoriatic arthritis (PsA). It considers the mechanism of …

Представлен обзор данных литературы, касающихся клинической эффективности и
безопасности тофацитиниба (ТОФА) в лечении псориатического артрита (ПсА) …

Amaç: Literatürde, iki oran arasındaki fark için güven aralığının belirlenmesi amacıyla çok
sayıda önerilmiş yöntem söz konusudur. Ancak spesifik olarak tedavi için gereken sayı …

Contingency space analysis (CSA) has been widely utilized as a measure of contingency for
decades. To date, a variety of associative measures (eg, Yule's Q, phi coefficient, operant …

Background: The purpose of this study was to investigate and predict ventilator-associated
pneumonia (VAP) in the two groups of patients who received either proton pump inhibitors …

Background: Smoking cessation/quitting smoking is among the most important health-
promoting life changes a person can make, and is the most cost-effective disease prevention …